Ustekinumab and Omalizumab

Supply of Ustekinumab and Omalizumab to NHS Scotland

Supply of Ustekinumab presentations to NHS Scotland. The Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of six (6) Framework Participants.

This Lot will be awarded from 1 October 2024, for 24 months, with an expiry date of 30 September 2026. This Lot has the option to extend by any number of periods, up to the

maximum 24 months.

Full details of Goods and volumes can be found within the ITT documents.

The buyer is using PCS-Tender to conduct this ITT exercise. The Project code is 26977. For more information see: http://www.publiccontractsscotland.gov.uk/info/InfoCentre.aspx?ID=2343

A sub-contract clause has been included in this contract. For more information see: http://www.publiccontractsscotland.gov.uk/info/InfoCentre.aspx?ID=2363

Community benefits are included in this requirement. For more information see: https://www.gov.scot/policies/public-sector-procurement/community-benefits-in-procurement/

A summary of the expected community benefits has been provided as follows:

Community benefits are required in this tender, details are available in the tender documents and relate to supporting the community benefit gateway